News

Novo Nordisk’s Wegovy debuts in India: How it works, who it’s for, and how much it costs
Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...
Anti-obesity mkt heats up as Mounjaro's Kwikpen version gets India approval
Eli Lilly receives approval for Mounjaro in prefilled Kwikpen as competition intensifies in India's weight-loss drug market ...
Wegovy: The price, perks, and pitfalls of India’s new weight-loss craze
Wegovy, the ₹26K/month weight-loss jab, hits India with bold promises—from fat loss to heart health. But is this pharma fix a ...
Novo Nordisk's $50 Obesity Shot Hits India -- The Drug War Just Got Real
Novo Nordisk is making a strategic move into one of the world's fastest-growing obesity markets by launching its blockbuster ...
Novo Nordisk aims for heavy sales in India with Wegovy
The achievement of that goal in India, which ranks third in obesity numbers after the US and China, will shatter the record ...
Novo Nordisk follows smart pricing for Wegovy in India; easy to use, says top local executive
We wanted to price it in India in a way which is comparable to the therapies that are available,' said Vikrant Shrotriya, ...
Novo Nordisk launches weight-loss drug Wegovy in India to compete with rival Lilly's Mounjaro
By Rishika Sadam and Kashish Tandon HYDERABAD (Reuters) -Danish drugmaker Novo Nordisk launched its blockbuster weight-loss ...